Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYQ00
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,366
Award facts
- Contract value 100% obligated
- $55,365.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,365.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order with an ultimate completion date of September 29, 2025. This award was made without a set-aside designation, allowing the contractor to compete directly in the broader federal procurement market. The order represents a single delivery against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program.
DMS Pharmaceutical Group holds a significant single-award IDC valued at $499,999,999 and valid through November 2026, which serves as the vehicle for this delivery order. The SPE2DB program enables the Defense Logistics Agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of medications including oncology treatments and specialty pharmaceuticals to Department of Defense healthcare sites across the country.
Quick answers
Who was awarded contract SPE2DB25FYQ00?
SPE2DB25FYQ00 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FYQ00 worth?
The government has obligated $55,366 on SPE2DB25FYQ00.
Is contract SPE2DB25FYQ00 an order under another contract?
Yes. SPE2DB25FYQ00 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ00 competed?
The extent of competition for SPE2DB25FYQ00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award